GGZ Centraal
11
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
1 terminated/withdrawn out of 11 trials
87.5%
+1.0% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Stress Autism Mate (SAM) App for Stress Management in Adults With Borderline Personality Disorder Traits
Role: lead
Effectiveness of a Waitlist App "Stappvoorstap" During Mental Healthcare Waiting Times
Role: lead
Qualitative Exploration of a Mobile Stress Management Intervention for Mental Health Workers
Role: collaborator
Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment
Role: lead
Evaluation of Combined Support for the Ambulatory Lifestyle Intervention
Role: lead
Evaluation of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness
Role: lead
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder
Role: collaborator
Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities
Role: lead
Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia
Role: lead
Cost-effectiveness of CYP2D6 and CYP2C19 Genotyping in Psychiatric Patients in Curacao
Role: lead
Study of the Effect of Imagery Rehearsal Therapy (IRT) of Nightmares
Role: lead
All 11 trials loaded